A Comparison of Optic Neuritis in Asian and in Western Countries

REFERENCES

• Shams PN, Plant GT. Optic neuritis: a review. Int MS J 2009;16:82–89.
   PubMedGoogle Scholar
• The Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991;109:1673–1678.
   Google Scholar
• The Optic Neuritis Study Group. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology 2008;115:1079–1082
   Google Scholar
• Wakakura M, Ishikawa S, Oono S, Tabuchi A, Kani K, Tazawa Y, Nakao Y, Kiyosawa M, Kawai K, Oohira A. [Incidence of acute idiopathic optic neuritis and its therapy in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)]. Nippon Ganka Gakkai Zasshi 1995;99:93–97. [In Japanese]
   PubMedGoogle Scholar
• Wakakura M, Minei-Higa R, Oono S, Matsui Y, Tabuchi A, Kani K, Shikishima K, Kawai K, Nakao Y, Tazawa Y, Kiyosawa M, Abe H, Ohba N, Yago K, Maeda S, Sugita M, Ishikawa S. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 1999;43:127–132.
   PubMed Web of Science ®Google Scholar
• Kuroiwa Y, Hung TP, Landsborough D, Park CS, Singhal BS. Multiple sclerosis in Asia. Neurology 1977;27:188–192.
   Google Scholar
• Singhal BS. Multiple sclerosis—Indian experience. Ann Acad Med Singapore 1985;14:32–36.
   Google Scholar
• Hung TP, Landsborough D, Hsi MS. Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 1976;27:459–484.
   Google Scholar
• Cheng Q, Miao L, Zhang J, Guan YT, Liu ZG, Wang X, Sun XJ, Zhao ZX, Song YJ, Ding XY, Guo ZI, Cheng XJ, Chen SD, Jiang GX, Fredrikson S. Clinical features of patients with multiple sclerosis from a survey in Shanghai, China. Mult Scler 2008;14:671–678.
   PubMed Web of Science ®Google Scholar
• Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430–1438.
   PubMed Web of Science ®Google Scholar
• Isayama Y, Takahashi T, Shimoyoma T, Yamadori A. Acute optic neuritis and multiple sclerosis. Neurology 1982;32:73–76.
   PubMed Web of Science ®Google Scholar
• Yang YF, Hou PK. Clinical study on acute optic neuritis. Taiwan J Ophthalmol 1967;6:47–55.
   Google Scholar
• Liu YS, Ko LS. Long term follow up of optic neuritis. Taiwan J Ophthalmol 1981;20:1–9.
   Google Scholar
• Woung LC, Ko LS. Long term follow up of optic neuritis: a study of contrast sensitivity. Taiwan J Ophthalmol 1985;24:208–215.
   Google Scholar
• Chang YC, Ko LS. Long term follow up of topic neuritis—visual functional evaluation. Taiwan J Ophthalmol 1986;25:351–362.
   Google Scholar
• Lin YC, Yen MY, Hsu WM, Lee HC, Wang AG. Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. Jpn J Ophthalmol 2006;50:170–175.
   PubMed Web of Science ®Google Scholar
• Lin JC, Jou JR, Liaw SL, Chen HR, Woung LC. Magnetic resonance imaging and computed tomography in optic neuritis. Taiwan J Ophthalmol 1996;35;57–62.
   Google Scholar
• Chang YC, Wu WC, Tsai RK. Prognosis of Taiwanese patients with isolated optic neuritis after intravenous methylprednisolone pulse therapy. J Formos Med Assoc 2007;106:656–663.
   Web of Science ®Google Scholar
• Bee YS, Lin MC, Wang CC, Sheu SJ. Optic neuritis: clinical analysis of 27 cases. Kaohsiung J Med Sci 2003;19:105–112.
   PubMedGoogle Scholar
• Wang JC, Tow S, Aung T, Lim SA, Cullen JF. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Experiment Ophthalmol 2001;29:312–315.
   PubMed Web of Science ®Google Scholar
• Lim SA, Goh KY, Tow S, Fu E, Wong TY, Seah A, Tan C, Cullen JF. Optic neuritis in Singapore. Singapore Med J 2008;49:667–671.
   PubMed Web of Science ®Google Scholar
• Jain IS, Munjal VP, Dhir SP, Gangwar DN. Profile of optic neuritis in Chandigarh and surrounding areas. Indian J Ophthalmol 1981;28:195–200
   Google Scholar
• Rodriguez M, Siva A, Cross SA, O’Brien PC, Kurland LT.. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45:244–250.
   PubMed Web of Science ®Google Scholar
• Woung LC, Lin CH, Tsai CY, Tsai MT, Jou JR, Chou P. Optic neuritis among National Health Insurance enrollees in Taiwan, 2000–2004. Neuroepidemiology 2007;29:250–254.
   Google Scholar
• Wilejto M, Shroff M, Buncic JR, Kennedy J, Goia C, Banwell B. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006;67:258–262.
   PubMedGoogle Scholar
• Kriss A, Francis DA, Cuendet F, Halliday AM, Taylor DS, Wilson J, Keast-Butler J, Batchelor JR, McDonald WI. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry 1988;51:1253–1258.
   PubMed Web of Science ®Google Scholar
• Miyazaki I. [Visual functions of optic neuritis in children caused by demyelinating disease]. Nippon Ganka Gakkai Zasshi 1991;95:995–1003. [In Japanese]
   Google Scholar
• Lee YC, Jou JR, Woung LC, Chen MS. Visual outcome of optic neuritis in children. Tzu Chi Med J 2001;13:155–159.
   Google Scholar
• Lucchinetti CF, Kiers L, O’Duffy A, O’Duffy A, Gomez MR, Cross S, Leavitt JA, O’Brien P, Rodriguez M. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997;49:1413–1418.
   PubMed Web of Science ®Google Scholar
• Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med 2006;354:1273–1280.
   PubMed Web of Science ®Google Scholar
• Beck RW, Trobe JD. What we have learned from the Optic Neuritis Treatment Trial. Ophthalmology 1995;102:1504–1508.
   PubMed Web of Science ®Google Scholar
• The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Neurology 1997;49:1404–1413
   Google Scholar
• Frederiksen JL, Sorensen TL, Sellebjerg FT. Residual symptoms and signs after untreated acute optic neuritis. A one-year follow-up. Acta Ophthalmol Scand 1997;75:544–547.
   Google Scholar
• Cleary PA, Beck RW, Bourque LB, Backlund JC, Miskala PH. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 1997;17:18–23.
   PubMed Web of Science ®Google Scholar
• Wakakura M, Mashimo K, Oono S, Matsui Y, Tabuchi A, Kani K. Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 1999;43:133–138
   PubMedGoogle Scholar
• Keltner JL, Johnson CA, Cello KE, Matsui Y, Tabuchi A, Kani K, Shikishima K, Kawai K, Nakao Y, Tazawa Y, Kiyosawa M, Abe H, Ohba N, Yago K, Maeda S, Sugita M, Ishikawa S. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol 2010;128:330–337.
   Google Scholar
• Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008;65:727–732.
   PubMedGoogle Scholar
• Foroozan R, Buono LM, Savino PJ, Sergott RC. Acute demyelinating optic neuritis. Curr Opin Ophthalmol 2002;13:375–380.
   PubMedGoogle Scholar
• Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, Téllez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008;70:1079–1083.
   PubMed Web of Science ®Google Scholar
• Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117–127.
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998;64:730–735
   PubMed Web of Science ®Google Scholar
• McDonnell GV, Hawkins SA. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1999;66:411.
   Google Scholar
• Kuroiwa Y. Clinical and epidemiological aspects of multiple sclerosis in Japan. Jpn J Med 1982;21:135–140.
   PubMedGoogle Scholar
• Yu YL, Woo E, Hawkins BR, Ho HC, Huang CY. Multiple sclerosis amongst Chinese in Hong Kong. Brain 1989;112:1445–1467.
   Google Scholar
• al-Din AS, el-Khateeb M, Kurdi A, Mubaidin A, Wriekat A, al-Shehab A, Khalil RW. Multiple sclerosis in Arabs in Jordan. J Neurol Sci 1995;131:144–149
   PubMed Web of Science ®Google Scholar
• Tsai CP, Yuan CL, Yu HY, Guo YC, Shan DE. Multiple sclerosis in Taiwan. J Chin Med Assoc 2004;67:500–505.
   Google Scholar
• Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT, Brodsky MC, Buckley EG, Chrousos GA, Corbett J, Eggenberger E, Goodwin JA, Katz B, Kaufman DI, Keltner JL, Kupersmith MJ, Miller NR, Nazarian S, Orengo-Nania S, Savino PJ, Shults WT, Smith CH, Wall M; Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003;121:944–949.
   PubMed Web of Science ®Google Scholar
• Soderstrom M. Optic neuritis and multiple sclerosis. Acta Ophthalmol Scand 2001;79:223–227.
   PubMedGoogle Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364:2106–2112.
   PubMed Web of Science ®Google Scholar
• Brusaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 2000;247:435–442.
   PubMed Web of Science ®Google Scholar
• Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993;111:773–775.
   PubMed Web of Science ®Google Scholar
• Sethi HS, Menon V, Sharma P, Khokhar S, Tandon R. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Indian J Ophthalmol 2006;54:177–183.
   Google Scholar
• Yen MY, Jaw SJ, Liu JH. Evaluation of steroids effect on optic neuritis. Taiwan J Ophthalmol 1989;28;318–321.
   Google Scholar
• Nakamura M, Nakazawa T, Doi H, Hariya T, Omodaka K, Misu T, Takahashi T, Fujihara K,Nishida K. Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol 2010;248:1777–1785.
   PubMed Web of Science ®Google Scholar
• O’Connor P. The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: a post hoc analysis of data from CHAMPS. Clin Ther 2003;25:2865–2874
   PubMed Web of Science ®Google Scholar
• Kinkel RP, Kollman C, O’Connor P, Murray TJ, Simon J, Arnold D, Bakshi R, Weinstock-Gutman B, Brod S, Cooper J, Duquette P, Eggenberger E, Felton W, Fox R, Freedman M,Galetta S, Goodman A, Guarnaccia J, Hashimoto S, Horowitz S, Javerbaum J, Kasper L,Kaufman M, Kerson L, Mass M, Rammohan K, Reiss M, Rolak L, Rose J, Scott T, Selhorst J,Shin R, Smith C, Stuart W, Thurston S, Wall M; CHAMPIONS Study Group. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 2006;66:678–684.
   PubMed Web of Science ®Google Scholar
• Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernández O, Hartung H, Seeldrayers P, Sørensen PS, Rovaris M, Martinelli V, Hommes OR; Early Treatment of Multiple Sclerosis Study Group. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001;357:1576–1582.
   PubMed Web of Science ®Google Scholar
• Kappos L, Polman CH, Freedman MS, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Bauer L, Jakobs P, Pohl C, Sandbrink R. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006;67:1242–1249.
   PubMed Web of Science ®Google Scholar
• Wang AG, Lin YC, Wang SJ, Tsai CP, Yen MY. Early relapse in multiple sclerosis-associated optic neuritis following the use of interferon beta-1a in Chinese patients. Jpn J Ophthalmol 2006;50:537–542.
   Google Scholar
• Warabi Y, Matsumoto Y, Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2007;252:57–61.
   PubMed Web of Science ®Google Scholar
• Chen YM, Yang CC, Wang IH, Hu FR, Jou JR. The effect of interferon beta-1a on optic neuritis relapse in patients with multiple sclerosis. Graefes Arch Clin Exp Ophthalmol 2010;248:231–235.
   Google Scholar
• Pro MJ, Pons ME, Liebmann JM, Ritch R, Zafar S, Lefton D, Kupersmith MJ. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci 2006;250:114–119.
   PubMed Web of Science ®Google Scholar
• Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freedman MS, Zackon DH, Kardon RH. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963–969.
   PubMed Web of Science ®Google Scholar
• Wang XL, Yu T, Xia DZ, Zhang JS, Yan QC, Luo YH. Measurement of retinal nerve fiber layer thickness in optic atrophy eyes of patients with optic neuritis using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2010;248:1013–1018.
   PubMed Web of Science ®Google Scholar